TCL Archive Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint November 25, 2011
Spotlight ArticleTCL Archive Cancer Program Advocate Mary Lasker, 93, Prodded Government, Scientists For Cures March 4, 1994